CSL Financial Statements From 2010 to 2024
| CMXHF Stock | USD 173.50 0.90 0.52% |
Check CSL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CSL's main balance sheet or income statement drivers, such as , as well as many indicators such as . CSL financial statements analysis is a perfect complement when working with CSL Valuation or Volatility modules.
CSL |
CSL Limited Company Operating Margin Analysis
CSL's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CSL Operating Margin | 0.28 % |
Most of CSL's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSL Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CSL Limited has an Operating Margin of 0.2809%. This is 100.8% lower than that of the Healthcare sector and 100.25% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 105.1% lower than that of the firm.
CSL Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSL's current stock value. Our valuation model uses many indicators to compare CSL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSL competition to find correlations between indicators driving CSL's intrinsic value. More Info.CSL Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSL Limited is roughly 2.46 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSL's earnings, one of the primary drivers of an investment's value.About CSL Financial Statements
CSL stakeholders use historical fundamental indicators, such as CSL's revenue or net income, to determine how well the company is positioned to perform in the future. Although CSL investors may analyze each financial statement separately, they are all interrelated. For example, changes in CSL's assets and liabilities are reflected in the revenues and expenses on CSL's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CSL Limited. Please read more on our technical analysis and fundamental analysis pages.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CSL Pink Sheet
CSL financial ratios help investors to determine whether CSL Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.